Residential substance abuse and
mental health facilities provide medical services, room, board, supervision and
counseling services to patients suffering from mental illness or substance
abuse.
Read Report at: https://www.thebusinessresearchcompany.com/report/residential-substance-abuse-and-mental-health-facilities-global-market-report-2018
The reasons for the market being
valued at $147 billion in 2017 is economic growth, socio-economic factors,
increased incidence of drug and alcohol abuse and integration driving the growth.
In the report, the global residential
substance and mental health facilities market is divided into two segments. Mental
health & intellectual disability facilities occupy the major share, accounting
for more than four-fifth of the market and substance abuse centers occupy
one-fifth of the market share.
Request a sample of the report at:
The USA was the largest country
in the residential substance abuse and mental health facilities market in 2017,
accounting for close to two-fifth of the market share. France and Germany
followed the USA as the next largest countries in the market.
The residential substance abuse and
mental health facilities market is fragmented with a number of large and small
organizations. The top five competitors in the market made up 25% of the
total market share in 2017. National Health Service was the largest competitor
of the market, followed by Universal Health Services, Acadia Healthcare
Company, Inc., Kindred Healthcare Inc. and Genesis Healthcare. The UK’s
National Health Service is the publicly funded health care system created under
the UK’s National Health Service Act. The organization was launched in 1948. It
has more than 1.5 million employees.
About The Business Research Company.
The
Business Research Company is a Business Intelligence Company which excels in
company, market and consumer research. It has
offices in the UK, the US and India and a network of trained researchers in 15
countries globally.
Contact Information.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315
623 0293
No comments:
Post a Comment